Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

Clinical trial NCT07746388 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07746388
Sponsor: University of Maryland, Baltimore
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nsclc NSCLC Stage II NSCLC, Stage III NSCLC Stage IIIB Resectable Lung Non-Small Cell Carcinoma

Start date: 2026-09-01
Primary completion: 2030-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.